LOS ANGELES, CA / ACCESS Newswire / March 18, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

When a virus infects a bacterial cell, the viral genome is the first component to be fully injected into the cell, making it an ideal immune target. A bacterial enzyme anchored to the membrane ...

Program will strengthen Washington state's leadership in protein science and accelerate translation of discoveries into new tools and companies across multiple applications SEATTLE, March 19, 2026 ...

Exozymes are advanced enzymes enhanced through bioengineering and AI to thrive in a bioreactor without using living cells. Exozymes can replace toxic petrochemical processes and inefficient ...

The Washington Research Foundation is investing $7 million in Nobel laureate David Baker's UW lab to turn AI-designed ...

The trajectory of base editing has been remarkable, progressing from the laboratory to patient care, treating debilitating or ...

San Francisco-based materials start-up Rubi has closed a $7.5 million funding round and secured more than $60 million in multiyear off-take term sheets with leading fashion and consumer goods brands, ...

RIKEN researchers have demonstrated a method that can detect tiny amounts of biomarkers in liquid samples and can distinguish ...

Explore 6 Maryland biotech companies with recent funding, ready to bring their breakthrough technologies to the clinic.

Scientists have found a way to boost the efficiency of rubisco — the enzyme that powers life on Earth — and hope to transfer it to crops.

Diagnosing some diseases could be as easy as breathing into a tube. MIT engineers have developed a test to detect ...